ProCE Banner Activity

How New Phase III Data From ADA 2021 Could Affect Your Diabetes Practice

Conference Coverage
Clinical Thought

From ADA 2021, updates from the phase III GRADE, SURPASS, and STEP trials.

Released: July 30, 2021

Expiration: July 29, 2022

Share

Faculty

Martin J Abrahamson

Martin J Abrahamson, MD, FACP

Associate Professor of Medicine
Harvard Medical School
Director, Division of CME
Department of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Merck

Faculty Disclosure

Primary Author

Martin J Abrahamson, MD, FACP

Associate Professor of Medicine
Harvard Medical School
Director, Division of CME
Department of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Martin J. Abrahamson, MD, FACP, has disclosed that he has received consulting fees from Novo Nordisk.